Werewolf Therapeutics Inc.
HOWL | NASDAQ
$0.98
$0 (0.00%)
Sep 22, 2026, 9:46 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 21M | n/a | n/a | n/a | n/a | 1.14M | 1.89M | 3.39M | 9.28M | 16.22M | 19.94M | 25.73M | 24.8M | 20.86M | 16.4M | 9.12M | 4.15M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.85M | 804K | 832K | 832K | 832K | 880K | 918K | 1.38M | 1.82M | 1.37M | 905K | 13.5M | 13.76M | 27.65M | 27.65M | 14.6M | 13.89M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 18.15M | -804K | -832K | -832K | -832K | 263K | 967K | 2.01M | 7.46M | 14.85M | 19.04M | 12.23M | 11.04M | -6.78M | -11.25M | -5.48M | -9.74M | n/a | n/a | n/a | n/a | n/a |
Operating Income | -25.57M | -51.65M | -60.68M | -71.61M | -73.01M | -74.42M | -73.59M | -66.21M | -58.34M | -45.44M | -40.5M | -40.72M | -44.01M | -52.91M | -56.06M | -60.76M | -62.02M | -58M | -50.09M | -39.6M | -31.85M | -25.96M |
Interest Income | 1.97M | 2.54M | 3.11M | 3.85M | 4.75M | 5.7M | 6.67M | 7.57M | 7.84M | 8M | 7.54M | 6.52M | 5.24M | 3.39M | 1.91M | 744K | 205K | 159K | 137K | 150K | 96K | 69K |
Pretax Income | -34.61M | -56.27M | -60.82M | -72.84M | -73.14M | -72.41M | -70.52M | -62.12M | -53.73M | -41.58M | -37.37M | -37.3M | -40.95M | -50.45M | -53.81M | -59.75M | -61.56M | -57.89M | -49.98M | -39.52M | -31.83M | -18.65M |
Net Income | -34.61M | -56.27M | -60.82M | -72.84M | -73.14M | -72.41M | -70.52M | -62.12M | -53.73M | -41.58M | -37.37M | -37.3M | -40.95M | -50.45M | -53.81M | -59.75M | -61.56M | -57.89M | -49.98M | -39.52M | -31.83M | -18.65M |
Selling & General & Admin | 19.35M | 16.07M | 15.85M | 17.98M | 18.49M | 18.47M | 18.13M | 17.86M | 17.57M | 17.76M | 18.21M | 21.26M | 20.69M | 21.35M | 20.79M | 17.87M | 18.15M | 16.6M | 14.82M | 12.44M | 9.67M | 7.27M |
Research & Development | 32.91M | 39.89M | 44.83M | 53.62M | 54.52M | 56.65M | 56.43M | 50.36M | 48.67M | 42.98M | 41.78M | 47.99M | 50.22M | 54.52M | 53.76M | 51.3M | 48.02M | 41.4M | 35.27M | 27.16M | 22.18M | 18.7M |
Other Expenses | -8.53M | -5.11M | -832K | -832K | -832K | -426K | n/a | n/a | -445K | -445K | -445K | -16.3M | -15.86M | -29.75M | -29.75M | -13.89M | -13.89M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 43.72M | 50.85M | 59.85M | 70.78M | 72.17M | 74.69M | 74.56M | 68.22M | 65.8M | 60.29M | 59.54M | 52.95M | 55.04M | 46.13M | 44.81M | 55.28M | 52.28M | 58M | 50.09M | 39.6M | 31.85M | 25.96M |
Interest Expense | 4.55M | 5.38M | 5.27M | 5.17M | 5.08M | 4.92M | 4.66M | 4.63M | 4.28M | 4.1M | 3.27M | 2.03M | 1.13M | 172K | n/a | n/a | n/a | n/a | n/a | n/a | 15K | 15K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -454K | -918K | -1.38M | -1.38M | -924K | -460K | 4.17M | 4.17M | 4.17M | 4.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 46.57M | 51.65M | 60.68M | 71.61M | 73.01M | 75.57M | 75.48M | 69.59M | 67.62M | 61.66M | 60.45M | 66.45M | 68.81M | 73.78M | 72.46M | 69.88M | 66.16M | 58M | 50.09M | 39.6M | 31.85M | 25.96M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 48.6M | 48.6M | 46.02M | 45.47M | 44.98M | 44.83M | 44.48M | 43.7M | 43.52M | 41.61M | 36.57M | 35.65M | 35.56M | 34.79M | 30.74M | 29.76M | 27.52M | 27.39M | 27.27M | 27.19M | 17.75M | 26.29M |
Shares Outstanding (Diluted) | 48.6M | 49.39M | 46.81M | 45.8M | 44.98M | 44.83M | 44.48M | 43.7M | 43.52M | 41.61M | 36.57M | 35.65M | 35.56M | 34.79M | 30.74M | 29.76M | 27.52M | 27.39M | 27.27M | 27.19M | 17.75M | 26.29M |
EPS (Basic) | -0.73 | -1.21 | -1.33 | -1.62 | -1.64 | -1.64 | -1.63 | -1.50 | -1.35 | -1.09 | -1.04 | -1.06 | -1.21 | -1.59 | -1.81 | -2.12 | -2.25 | -5.55 | -8.89 | -8.23 | -8.40 | -4.33 |
EPS (Diluted) | -0.73 | -1.21 | -1.33 | -1.62 | -1.64 | -1.64 | -1.63 | -1.50 | -1.35 | -1.09 | -1.04 | -1.06 | -1.21 | -1.59 | -1.81 | -2.12 | -2.25 | -5.55 | -8.89 | -8.23 | -8.40 | -4.33 |
EBITDA | -22.02M | -49.28M | -53.91M | -65.99M | -66.34M | -65.72M | -64.05M | -55.66M | -47.62M | -35.68M | -32.34M | -33.55M | -37.84M | -48.54M | -52.4M | -58.71M | -61.17M | -57.62M | -49.78M | -39.31M | -31.63M | -25.8M |
EBIT | -25.67M | -50.89M | -55.55M | -67.67M | -68.07M | -67.5M | -65.86M | -57.49M | -49.45M | -37.48M | -34.1M | -35.27M | -39.83M | -50.28M | -53.81M | -59.75M | -61.56M | -57.89M | -50M | -39.52M | -31.82M | -25.96M |
Depreciation & Amortization | 3.65M | 1.61M | 1.63M | 1.68M | 1.73M | 1.78M | 1.81M | 1.83M | 1.82M | 1.8M | 1.76M | 1.72M | 1.98M | 1.74M | 1.41M | 1.04M | 398K | 275K | 216K | 212K | 186K | 166K |
Add to Watchlist
Select watchlists to add or remove HOWL